Skip to search.
 TSX Down 0.90% TSX Ventures Down 1.16%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
9.14 Down 0.33(3.48%) May 26, 4:00PM EDT
Add to Portfolio
Prev Close:9.47
Open:9.43
Bid:9.10 x 1000
Ask:9.86 x 1500
1y Target Est:15.50
Beta:0.45
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:9.04 - 9.46
52wk Range:2.31 - 14.40
Volume:2,067,555
Avg Vol (3m):4,406,140
Market Cap:1.17B
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ZIOPDown 3.48%1.17B
IMGNUp 0.45%769.63M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):839.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.68
Quarterly EPS Est (Jun-15) :-0.10
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback